Newton Biocapital II (Public limited company)
Newton Biocapital II is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0779.335.513. It was founded on 24-12-2021. Its registered office is in Woluwe-Saint-Pierre. Its main activity is: Financial service activities, except insurance and pension funding. Its annual accounts for 2025 report equity of € 24 576 414 and a loss of € 824 565. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 18-10-2026.
Company information
Key figures of Newton Biocapital II
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -824 565+83 % | € -4 778 528-223 % | € -1 479 757+2 % | € -1 516 035 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 24 576 414+43 % | € 17 191 016+36 % | € 12 602 651+10 % | € 11 456 146 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 24 624 542+43 % | € 17 254 739+36 % | € 12 641 889+9 % | € 11 633 983 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -912 088+36 % | € -1 433 922+3 % | € -1 477 469+2 % | € -1 507 806 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - | - |
Financial estimate
- 3 Shareholders
- 3 Subsidiaries
- 6 Board links
Similar companies
Other companies in the same activity in Woluwe-Saint-Pierre.
| Company | Town |
|---|---|
| Bruxelles - Propreté, Agence régionale pour la propreté | 1150 Woluwe-Saint-Pierre |
| Société Belge d'Etudes et de Participations | 1150 Woluwe-Saint-Pierre |
| Lendit-Lier | 1150 Woluwe-Saint-Pierre |
| Services latino-américains , africains et asiatiques de Promotion de l'Habitation populaire | 1150 Woluwe-Saint-Pierre |
| Monteignies R. J. et Cie | 1150 Woluwe-Saint-Pierre |
| Finindex | 1150 Woluwe-Saint-Pierre |
| OCTA+ GROUP | 1150 Woluwe-Saint-Pierre |
| NITRAMCO | 1150 Woluwe-Saint-Pierre |
Frequently asked questions
Is Newton Biocapital II still active? Yes. The Crossroads Bank for Enterprises lists Newton Biocapital II as active.
What is the VAT number of Newton Biocapital II? Newton Biocapital II is not registered for VAT. Its enterprise number is 0779.335.513.
When was Newton Biocapital II founded? Newton Biocapital II was founded on 24-12-2021.
What is the address of Newton Biocapital II? The current registered office of Newton Biocapital II is Avenue de Tervueren 273, 1150 Woluwe-Saint-Pierre.
When did Newton Biocapital II last file annual accounts? The latest annual accounts of Newton Biocapital II were filed on 01-06-2026.
Does Newton Biocapital II file its annual accounts on time? Yes. Newton Biocapital II filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is Newton Biocapital II financially healthy? Addrly gives Newton Biocapital II a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Newton Biocapital II profitable? The annual accounts of Newton Biocapital II for 2025 show a loss of € 824 565.
What is the equity of Newton Biocapital II? The equity of Newton Biocapital II was € 24 576 414 at the close of the 2025 financial year.
Who are the directors of Newton Biocapital II? The annual accounts of Newton Biocapital II record 5 mandates. The names, roles and dates are visible with a free account.
Can Newton Biocapital II receive Peppol e-invoices? Yes. Newton Biocapital II is registered on the Peppol network and can receive structured electronic invoices.
What does Newton Biocapital II do? The main activity of Newton Biocapital II is: Financial service activities, except insurance and pension funding.